Insider Trading Alert: Vertex Pharmaceuticals (NASDAQ:VRTX) Executive Sells $1.1M Worth of Stock – What Does This Mean for Investors?
In a recent transaction, Dr. Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals, sold over 2,000 shares of the company's stock. Find out the details and implications of this insider trading activity.
Vertex Pharmaceuticals is a leading biopharmaceutical company focusing on cystic fibrosis treatment. Recent developments include positive clinical trials and financial performance, with revenue growth and new drug applications.
InvestingPro Insights: Vertex's stock is trading near its 52-week high, reflecting strong financials and positive investor sentiment. Learn more about Vertex's performance and market position with exclusive InvestingPro Tips.
Don't miss out on this opportunity to stay informed and make informed investment decisions. Visit now and use the code PRONEWS24 for a discount on your subscription.